Lithium Hexamethyldisilazide → HCID 90110410, compound
Reaction equation
[CH3:1][O:2][C:3]1[CH:17]=[C:16]([O:18][CH3:19])[CH:15]=[CH:14][C:4]=1[CH2:5][NH:6][C:7]1[CH:12]=[CH:11][CH:10]=[C:9]([F:13])[N:8]=1.[Li+].C[Si]([N-][Si](C)(C)C)(C)C.[CH3:30][C:31]1[CH:39]=[C:38]2[C:34]([CH:35]=[N:36][NH:37]2)=[CH:33][C:32]=1[S:40](Cl)(=[O:42])=[O:41]>C1COCC1>[CH3:1][O:2][C:3]1[CH:17]=[C:16]([O:18][CH3:19])[CH:15]=[CH:14][C:4]=1[CH2:5][N:6]([C:7]1[CH:12]=[CH:11][CH:10]=[C:9]([F:13])[N:8]=1)[S:40]([C:32]1[CH:33]=[C:34]2[C:38](=[CH:39][C:31]=1[CH3:30])[NH:37][N:36]=[CH:35]2)(=[O:42])=[O:41]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- -78 °C
Procedure
Added N-(2,4-dimethoxybenzyl)-6-fluoropyridin-2-amine (1.0 g, 3.87 mmol) to THF (19 mL) and cooled to −78° C. Added LHMDS (6.5 mL, 6.45 mmol), warmed to RT, stirred for 30 min, and cooled back to −78° C. Following addition of LHMDS, solution turned clear and pink in color. After warming to RT, solution became clear, yellow. At −78° C., added 6-methyl-1H-indazole-5-sulfonyl chloride (4-4, 594.8 mg, 2.58 mmol) in THF (6.5 mL) at −78° C. via syringe followed by THF rinse. Solution remained yellow in color. Allowed reaction flask to remain in bath and gradually warm to RT overnight. Following this duration, quenched with 40 mL saturated NH4Cl, diluted with 20 mL EtOAc. Separated layers, back-extracted aqueous with 3×10 mL EtOAc. Dried organics over Na2SO4, filtered, concentrated to give an orange oil. Purified by normal-phase ISCO (40 g column, 0-50% EtOAc:Hex) to give 4-5 as a white solid.
Workup
- temperaturecooled back to −78° C
- temperatureAfter warming to RT
- washrinse
- customAllowed reaction flask to remain in bath
- temperaturegradually warm to RT overnight
- customquenched with 40 mL saturated NH4Cl
- additiondiluted with 20 mL EtOAc
- extractionSeparated layers, back-extracted aqueous with 3×10 mL EtOAc
- filtrationDried organics over Na2SO4, filtered
- concentrationconcentrated
- customto give an orange oil
- customPurified by normal-phase ISCO (40 g column, 0-50% EtOAc:Hex)
Sources & evidence
- ORD record
- ord-45b1a208120f481a859553ca494df4c6
- Source dataset
- uspto-grants-2016_07
- Patent number
- US09388179B2
Reaction notes
Loading…